Internal Medicine, Gastroenterology · Huntington, NY
NPI
1598793937
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
789 Park Ave
Huntington, NY, 11743
Phone (631) 425-2160
Groups this clinician bills Medicare through
Medicare paid, 2024
$162K
1,096 services
Medicare patients, 2024
527
Average age 76
Drug cost, 2024
$537K
1,721 prescriptions
Company payments, 2025
$114
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barry Glanzman was code 99214 (office e&m - established), 350 times for 251 patients. In total Barry Glanzman billed 1,096 services in 23 codes, and Medicare paid $162K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 350 | 251 | $100.04 | $35K |
| 99213 Office E&M - Established | Office | 195 | 159 | $68.70 | $13K |
| 43239 Upper GI Endoscopy | Office | 90 | 89 | $262.49 | $24K |
| 99203 Office E&M - New | Office | 83 | 83 | $79.31 | $6,583 |
| 99204 Office E&M - New | Office | 77 | 77 | $107.83 | $8,303 |
| 45380 Lower GI Endoscopy - Other | Office | 73 | 72 | $295.56 | $22K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Office | 54 | 53 | $310.28 | $17K |
| 45378 Lower GI Endoscopy - Other | Office | 46 | 44 | $220.46 | $10K |
| 99215 Office E&M - Established | Office | 31 | 28 | $141.08 | $4,374 |
| 45385 Colonoscopy - Lesion Removal | Office | 23 | 23 | $356.28 | $8,194 |
| 43235 Upper GI Endoscopy | Office | 15 | 14 | $177.85 | $2,668 |
| 99202 Office E&M - New | Office | 12 | 12 | $53.49 | $642 |
By year: 2022 $309K for 1,639 services; 2023 $192K for 1,038 services; 2024 $162K for 1,096 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82270 Immunoassay | 23 | 23 | $4.33 | $99.65 |
Medicare prescription drug claims, 2024
In 2024, the drug Barry Glanzman prescribed most often to Medicare patients was Pantoprazole Sodium, with 407 prescriptions and refills. In total Barry Glanzman wrote 1,721 Medicare prescriptions that cost $537K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 407 | 823 | 124 | $3,966 |
| Omeprazole Generic | 239 | 540 | 73 | $2,949 |
| Famotidine Generic | 187 | 466 | 50 | $2,480 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 117 | 117 | 111 | $7,093 |
| Linzess Linaclotide | 70 | 115 | 13 | $60K |
| Voquezna Vonoprazan Fumarate | 57 | 79 | 20 | $47K |
| Mesalamine Generic | 54 | 115 | 14 | $47K |
| Esomeprazole Magnesium Generic | 42 | 82 | Under 11 | $1,320 |
| Creon Lipase/Protease/Amylase | 41 | 67 | 11 | $158K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 40 | 40 | 39 | $590 |
| Amitriptyline Hcl Generic | 32 | 68 | 12 | $447 |
| Ursodiol Generic | 28 | 72 | Under 11 | $7,468 |
| Ondansetron Odt Ondansetron | 24 | 25 | Under 11 | $475 |
| Rabeprazole Sodium Generic | 24 | 47 | Under 11 | $746 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 21 | 21 | 21 | $3,333 |
Brand drugs: 325 claims; generic drugs: 1,396 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Barry Glanzman $114 ($114 in general payments such as food, travel and fees) from 2 companies. The largest payer was QOL Medical, LLC with $58.31.
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 2 | $58.31 |
| Abbvie Inc. ABBV | 3 | $55.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.